Selected article for: "confidence interval and relative risk"

Author: Chang Chen; Jianying Huang; Zhenshun Cheng; Jianyuan Wu; Song Chen; Yongxi Zhang; Bo Chen; Mengxin Lu; Yongwen Luo; Jingyi Zhang; Ping Yin; Xinghuan Wang
Title: Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial
  • Document date: 2020_3_20
  • ID: 14he8n3u_41
    Snippet: Additionally, because of the complexity of the disease, progression from moderate to severe/critical is possible. Terminating trial treatment to such patients from the study was considered unacceptable. Post-hoc analysis showed that both treatment and clinical classification contributed significantly to the primary outcome of clinical recovery rate at Day 7. Difference of the frequency of severe/critical patients between groups reached a marginal.....
    Document: Additionally, because of the complexity of the disease, progression from moderate to severe/critical is possible. Terminating trial treatment to such patients from the study was considered unacceptable. Post-hoc analysis showed that both treatment and clinical classification contributed significantly to the primary outcome of clinical recovery rate at Day 7. Difference of the frequency of severe/critical patients between groups reached a marginal significance, which made an important impact on the trial outcome.

    Search related documents:
    Co phrase search for related documents